Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial active not recruiting, estimated primary completion Jan 2026. No public readout, topline results, or efficacy data found in searches across web, ClinicalTrials.gov, Amgen sites. No publications or press releases on outcomes.
Found Apr 6, 2026, 2:57 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Will the results be positive?
No public readout or results posted for this exact Phase 2 trial (NCT06054113). Primary completion is Jan 2026; trial is active not recruiting. General blinatumomab pediatric R/R B-ALL studies are positive, but no trial-specific efficacy interpretation (CR/CRh rates framed as success/failure) found.
Found Apr 6, 2026, 2:08 PMReviewed Apr 6, 2026, 2:23 PM
NO_DECISIONDismissed90% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
This exact Phase 2 trial has no public efficacy readout yet. The ClinicalTrials.gov record shows primary completion on 2026-01-05, but the study page still states "No Results Posted." Without a trial-specific public interpretation, it cannot be classified positive or negative.
Found Apr 3, 2026, 5:20 PMReviewed Apr 3, 2026, 5:20 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
There is no clear public efficacy readout for this exact Phase 2 trial to classify as positive or negative. The trial record still shows the study as active, not recruiting, and explicitly says no results are posted. A separate trial-tracking source also labels NCT06054113 as an ongoing trial. Without a trial-specific public results interpretation, the correct classification is no_decision.
Found Mar 30, 2026, 4:37 AMReviewed Mar 30, 2026, 7:04 AM